TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$61.21
-2.75 (-4.30%)
Performance
1D
—
1W
—
1M
—
3M
-6.55%
6M
-15.91%
1Y
+36.75%
YTD
-24.22%
Open$63.96
Previous Close$63.96
Day High$64.01
Day Low$59.35
52W High$85.25
52W Low$38.51
Volume—
Avg Volume704.8K
Market Cap2.72B
P/E Ratio—
EPS$-1.61
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$73.37
Below
SMA 200
$59.46
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+33.2% upside
Current
$61.21
$61.21
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 480.37M | 141.37M | 563.29M |
| Net Income | -70,688,696 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -74,833,252 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |